How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,102 results for

Tobacco Cessation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness

Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost-Effectiveness Pharmacist-Led Interventions for Tobacco Smoking Cessation: A Review of Clinical Effectiveness and Cost (...) -Effectiveness Last updated: September 9, 2019 Project Number: RC1174-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of pharmacist-led tobacco smoking cessation interventions? What is the cost-effectiveness of pharmacist-led tobacco smoking cessation interventions versus self-directed smoking cessation interventions? Key Message Three systematic reviews were identified regarding the clinical

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

4. Tobacco Cessation

Tobacco Cessation Tobacco Cessation - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Tobacco Cessation Tobacco use is the leading preventable cause of premature death in Canada Nicotine addiction is regarded as a chronic medical condition; now classified in the Diagnostic and Statistical Manual of Mental Disorders as tobacco use disorder Prevalence in Canada is approximately 16 %; in Saskatchewan over 20 % Detrimental effects (...) suggested, but if the patient is not interested, you may still prescribe treatment. While varenicline has the highest quit rates, therapy should be tailored to the individual’s needs and preferences. (Level 1C Recommendation) Combination pharmacotherapy may be warranted in cases of previous unsuccessful attempts with monotherapy, or patient preference. 1. Non-pharmacological treatments for tobacco cessation: Counseling and psychosocial support programs (e.g. ) . Cognitive Behavioral Therapy Motivational

2019 medSask

5. Tobacco cessation interventions for young people. (PubMed)

Tobacco cessation interventions for young people. Most tobacco control programmes for adolescents are based around prevention of uptake, but teenage smoking is still common. It is unclear if interventions that are effective for adults can also help adolescents to quit. This is the update of a Cochrane Review first published in 2006.To evaluate the effectiveness of strategies that help young people to stop smoking tobacco.We searched the Cochrane Tobacco Addiction Group's Specialized Register (...) in June 2017. This includes reports for trials identified in CENTRAL, MEDLINE, Embase and PsyclNFO.We included individually and cluster-randomized controlled trials recruiting young people, aged under 20 years, who were regular tobacco smokers. We included any interventions for smoking cessation; these could include pharmacotherapy, psycho-social interventions and complex programmes targeting families, schools or communities. We excluded programmes primarily aimed at prevention of uptake. The primary

Full Text available with Trip Pro

2017 Cochrane

6. Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines

Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Integrated Cessation Programs for Adults Who Smoke Cannabis and Tobacco: Clinical Effectiveness and Guidelines Published (...) on: September 28, 2017 Project Number: RA0934-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of integrated cessation programs in adults who smoke cannabis and tobacco? What are the evidence-based guidelines associated with the use of integrated cessation programs in adults who smoke cannabis and tobacco? Key Message One systematic review with meta-analysis and one randomized controlled trial were identified

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

7. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. (PubMed)

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Smoking rates in people with alcohol and other drug dependencies are two to four times those of the general population. Concurrent treatment of tobacco dependence has been limited due to concern that these interventions are not successful in this population or that recovery from other addictions could be compromised if tobacco cessation was combined with other drug dependency (...) treatment.To evaluate whether interventions for tobacco cessation are associated with tobacco abstinence for people in concurrent treatment for or in recovery from alcohol and other drug dependence.We searched the Cochrane Tobacco Addiction Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and clinicaltrials.gov databases, with the most recent search completed in August 2016. A grey literature search of conference abstracts from the Society on Nicotine

Full Text available with Trip Pro

2016 Cochrane

8. Interventions for tobacco use cessation in people living with HIV and AIDS. (PubMed)

Interventions for tobacco use cessation in people living with HIV and AIDS. Tobacco use is highly prevalent amongst people living with HIV/AIDS (PLWHA) and has a substantial impact on morbidity and mortality.To assess the effectiveness of interventions to motivate and assist tobacco use cessation for people living with HIV/AIDS (PLWHA), and to evaluate the risks of any harms associated with those interventions.We searched the Cochrane Tobacco Addiction Group's Specialised Register, Cochrane (...) Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and PsycINFO in June 2015. We also searched EThOS, ProQuest, four clinical trial registries, reference lists of articles, and searched for conference abstracts using Web of Science and handsearched speciality conference databases.Controlled trials of behavioural or pharmacological interventions for tobacco cessation for PLWHA.Two review authors independently extracted all data using a standardised electronic data collection form

Full Text available with Trip Pro

2016 Cochrane

9. WHO monograph on tobacco cessation and oral health integration

WHO monograph on tobacco cessation and oral health integration WHO monograph on tobacco cessation and oral health integration JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO monograph on tobacco cessation and oral health integration View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO monograph on tobacco cessation and oral

2017 WHO

10. Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness

Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness | CADTH.ca Find the information you need Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness Nicotine Replacement Therapy, Bupropion and Varenicline for Tobacco Cessation: A Review of Clinical Effectiveness (...) reporting no difference and one study reporting higher rates of abstinence for those on NRT. Tags bupropion, nicorette, nicotine, nicotine patch, tobacco use cessation products, wellbutrin, addiction, Champix, Chantix, Zyban, nicotine gum, nicotine patches, nicotine replacement, nicotine replacements, varenicline Files Rapid Response Summary with Critical Appraisal Published : March 8, 2016 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

11. The effectiveness of university-based tobacco cessation programs on tobacco consumption behaviour of university students

The effectiveness of university-based tobacco cessation programs on tobacco consumption behaviour of university students Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

12. Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates. (PubMed)

Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates. Smoking remains the leading cause of preventable disease and death in the developed world that kills half of all long-term users. Tobacco use after solid organ transplantation is associated with allograft dysfunction, cancer, and reduced overall survival.In this single-center, retrospective study, we describe the frequency of tobacco use after (...) lung transplantation (LTx), pre-transplant patient characteristics associated with tobacco use, and the safety, efficacy and outcomes of post-transplant tobacco cessation interventions.Four percent of our LTx cohort resumed tobacco use post-transplant. Chronic obstructive pulmonary disease (COPD) (p= 0.043), the cessation duration prior to LTx (p<0.001), and the packyear-cessation-index (PCI) (p<0.001) were found to be significantly associated with tobacco use post-transplant. A PCI cut-off value

2019 Transplantation

13. User characteristics of national smoking cessation services in Korea: who chooses each type of tobacco cessation program? (PubMed)

User characteristics of national smoking cessation services in Korea: who chooses each type of tobacco cessation program? Relatively little is known about which characteristics of smokers are related to choosing a specific type of smoking cessation service. The user characteristics of different smoking cessation services were compared to determine the service preferred by user characteristics.The characteristics of adult smokers from Korea National Health and Nutrition Examination Survey (3762 (...) ) and registered users of national smoking cessation services operated through the web (14,762), at Public Health Center-based Smoking Cessation Clinics (PHC-based SCCs) (335,532), and by telephone (Quitline) (2983) were compared.Females and younger aged were more in web and telephone-based cessation service users, while aged 50 years or older were more in PHC-based SCCs users. Although manufacturing and production workers were the most prevalent among smokers in the general population, office workers

Full Text available with Trip Pro

2019 BMC health services research

14. Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study). (PubMed)

Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study). The aim of this study was to assess public acceptance of four possible healthcare policies supporting tobacco dependence treatment in line with the Framework Convention for Tobacco Control, Article 14 recommendations in Germany.Cross-sectional household survey.Data were drawn from the German population and collected through computer (...) diseases (OR 0.74, 95% CI 0.60 to 0.91) and free provision of treatment (OR 0.80, 95% CI 0.66 to 0.97). Offering cessation treatment to smokers with physical disorders was generally more accepted than to those with mental health issues.The majority of the German population supports healthcare policies to improve the availability and affordability of tobacco dependence treatment. Non-smokers were more supportive than current smokers of two of the four policies, but odds of support were only about 40

2019 BMJ open

15. Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001-2014. (PubMed)

Trends in tobacco use and tobacco cessation counselling codes among Medicare beneficiaries, 2001-2014. Analysis of Medicare data is often used to determine epidemiology, healthcare utilization and effectiveness of disease treatments. We were interested in whether Medicare data could be used to estimate prevalence of tobacco use. Currently, data regarding tobacco use is derived from Behavioral Risk Factor Surveillance System (BRFSS) survey data. We compare administrative claims data for tobacco (...) diagnosis among Medicare beneficiaries to survey (BRFSS) estimates of tobacco use from 2001 to 2014.Retrospective cross-sectional study comparing tobacco diagnoses using International Classification of Disease, Ninth Revision (ICD-9) codes for tobacco use in Medicare data to BRFSS data from 2001 to 2014 in adults age ≥ 65 years. Beneficiary data included age, gender, race, socioeconomic status, and comorbidities. Tobacco cessation counselling was also examined using Healthcare Common Procedure Coding

2019 BMC health services research

16. Impact of a tobacco cessation intervention on adherence to tobacco use treatment guidelines among village health workers in Vietnam. (PubMed)

Impact of a tobacco cessation intervention on adherence to tobacco use treatment guidelines among village health workers in Vietnam. Community health workers (in Vietnam referred to as village health workers) have the potential to play a key role in expanding access to evidence-based tobacco use treatment. We conducted a cluster randomized controlled trial in community health centers in Vietnam that compared the effect of provider advice and cessation assistance (i.e. brief counseling (...) and patient education materials) (BC) vs. BC + three sessions of in-person counseling delivered by a village health worker (BC+R) on providers' and village health workers' adherence to tobacco use treatment guidelines. All village health workers and health care providers received training. This paper presents data on the effect of the intervention on village health workers' adherence to tobacco use treatment guidelines, including asking about tobacco use, advising smokers to quit, offering assistance

2019 Global health promotion Controlled trial quality: uncertain

17. Tobacco Cessation on Prescription as a primary health care intervention targeting a context with socioeconomically disadvantaged groups in Sweden: A qualitative study of perceived implementation barriers and facilitators among providers. (PubMed)

Tobacco Cessation on Prescription as a primary health care intervention targeting a context with socioeconomically disadvantaged groups in Sweden: A qualitative study of perceived implementation barriers and facilitators among providers. A new intervention, Tobacco Cessation on Prescription (TCP), has been developed in the Swedish primary health care (PHC) setting to address inequalities in health caused by tobacco use. It consists of counseling for at least 10 minutes, an individualized (...) prescription of tobacco cessation treatment and follow-up on at least one occasion. TCP is currently being tested in clinical practice for the first time but there is a lack of knowledge about how it is perceived by health care providers.To explore PHC provider's perceived barriers and facilitators of implementing TCP as an intervention targeting a context with socioeconomically disadvantaged groups in Sweden.Directed content analysis of transcripts from eight semi-structured interviews and one focus group

Full Text available with Trip Pro

2019 PLoS ONE

18. Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature (PubMed)

Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature Programmed death ligand 1 (PD-L1) targeting immunotherapies, as pembrolizumab and nivolumab, have significantly improved outcome in patients with non-small cell lung cancer (NSCLC). Tobacco smoking is the number one risk factor for lung cancer and is linked to 80%-90% of these cancers. Smoking during cancer therapy may influence on radiotherapy and chemotherapy outcome. We aimed (...) to review the knowledge in immunotherapy.A systematic review was done. We searched for documents and articles published in English language and registered in Cochrane Library, National Health Service (NHS) Centre for Reviews and Dissemination (CRD), Embase or Medline. The search terms were (A) (Lung cancer or NSCLC) with (pembrolizumab or nivolumab) with PD-L1 with (tobacco or smoking) and (B) Lung Neoplasms and Immunotherapy and (smoking cessation or patient compliance). 68 papers were detected and two

Full Text available with Trip Pro

2018 ESMO open

19. Factors Affecting Smoking Cessation Success of Heavy Smokers Registered in the Intensive Care Smoking Cessation Camp (Data from the National Tobacco Control Center) (PubMed)

Factors Affecting Smoking Cessation Success of Heavy Smokers Registered in the Intensive Care Smoking Cessation Camp (Data from the National Tobacco Control Center) The purpose of this study was to investigate the factors involved in the success of smoking cessation in heavy smokers enrolled in an intensive care smoking cessation camp program.Heavy smokers enrolled in the program were classified into a success (n = 69) or failure (n = 29) group, according to whether they maintained smoking (...) cessation for 6 months after the end of the program. Demographics, smoking behaviors, and smoking cessation-related characteristics were analyzed.Statistically significantly more participants in the success group had a spouse (98.6%; p = 0.008) compared with participants in the failure group (82.8%). However, multivariate logistic regression analysis indicated that having a spouse was not an independent factor in smoking cessation (p = 0.349). A significant difference in the frequency of counseling

Full Text available with Trip Pro

2018 Osong public health and research perspectives

20. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial

Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial Incorporating tobacco treatment within lung cancer screening programs has the potential to influence cessation in high-risk smokers. We aimed to better understand the characteristics of smokers within a screening cohort, correlate those variables with downstream outcomes, and identify predictors of continued smoking.This study is a secondary analysis (...) of the National Lung Screening Trial randomized clinical study. Tobacco dependence was evaluated by using the Fagerstrӧm Test for Nicotine Dependence, the Heaviness of Smoking Index, and time to first cigarette (TTFC); descriptive statistics were performed. Clinical outcomes (smoking cessation, lung cancer, and mortality) were assessed with descriptive statistics and χ2 tests stratified according to nicotine dependence. Logistic and Cox regression models were used to study the influence of dependence

Full Text available with Trip Pro

2018 EvidenceUpdates

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>